amakuru
Amakuru

Daiichi Sankyo atangaza ibyavuye mu rubanza rwo gukingira Booster

Tokiyo, Ubuyapani - (15 Ugushyingo 2022) - Daiichi Sankyo (TSE: 4568) uyu munsi yatangaje ko mu rubanza rwo gusuzuma imikorere n’umutekano w’urukingo rwa booster hamwe na DS-5670, urukingo rwa mRNA rurwanya indwara yanduye ya coronavirus (COVID) -19) itezwa imbere na Daiichi Sankyo (nyuma, ikizamini cyo gukingira booster), iherezo ryibanze ryagezweho.Ikigeragezo cyo gukingira booster cyarimo abagera ku 5.000 b’Abayapani bafite ubuzima bwiza n’abasaza barangije icyiciro cya mbere (dosiye ebyiri) z’inkingo za mRNA zemejwe mu Buyapani nibura amezi atandatu mbere yo kwiyandikisha.Muri Mutarama 2022, urubanza rwatangijwe nk'icyiciro cya 1/2/3 hagamijwe gusuzuma imikorere n'umutekano byo gukingira booster hamwe na DS-5670 hakoreshejwe inkingo za mRNA zemejwe mu Buyapani nk'igenzura.GMFR yo gutesha agaciro titerite ya antibody irwanya SARS-CoV-2 (umwimerere wumwimerere) mumaraso nyuma yibyumweru bine nyuma yo gukingirwa kwa booster, iherezo ryibanze ryikigereranyo cyo gukingira booster, yerekanye imibare ihanitse kandi itari munsi ya DS-5670 kurukingo rwa mRNA ( umwimerere wumwimerere) byemewe mubuyapani, kugera kubigenewe.Nta mpungenge z'umutekano zagaragaye.Ibisubizo birambuye byikizamini cyo gukingira booster bizerekanwa mumanama yamasomo no mubipapuro byubushakashatsi.Hashingiwe ku byavuye mu igeragezwa, Daiichi Sankyo azakomeza kwitegura gukoresha imiti mishya y’urukingo rwa mRNA muri Mutarama 2023. Byongeye kandi, Daiichi Sankyo arateganya gukora ibizamini by’amavuriro by’inkingo zingana n’ubwoko bwa mbere na Omicron kurwanya coronavirus nshya, bikomeje guhinduka.Daiichi Sankyo azaharanira gushimangira iterambere ry’urukingo rwa mRNA no kubyaza umusaruro umusaruro kugira ngo itangwe neza mu bihe bisanzwe ndetse no gutanga inkingo byihuse mu gihe habaye icyorezo cy’indwara zandura kandi zigaruka.

Hafi ya DS-5670 DS-5670 ni urukingo rwa mRNA rurwanya COVID-19 hakoreshejwe ikoranabuhanga rishya ryo gutanga aside nucleic yavumbuwe na Daiichi Sankyo, ryagenewe gukora antibodies zirwanya reseptor zihuza (RBD) za poroteyine ya spike ya roman coronavirus, bityo biteganijwe ko hakumirwa gukumira COVID-19 na 2 umutekano.Byongeye kandi, Daiichi Sankyo igamije inkingo za mRNA zishobora gukwirakwizwa mu bushyuhe bwa firigo (2-8 ° C)

img1

Igihe cyo kohereza: Ukuboza-17-2022